rxstatShortages › Pindolol

Pindolol (Visken) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Pindolol products are in shortage in Canada (2 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

A beta blocker used to treat high blood pressure.

Products affected
2 / 10
In shortage since
May 1, 2025
Reports on file
21
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
VISKEN
10MG · TABLET · XEDITON PHARMACEUTICALS INC
DIN 00443174 · since May 1, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
VISKEN
5MG · TABLET · XEDITON PHARMACEUTICALS INC
DIN 00417270 · since May 1, 2025, no end estimate · Disruption of the manufacture of the drug.
Discontinued
TEVA-PINDOLOL
5MG · TABLET · TEVA CANADA LIMITED
DIN 00869007
Discontinued
TEVA-PINDOLOL
10MG · TABLET · TEVA CANADA LIMITED
DIN 00869015
Resolved
TEVA-PINDOLOL
15MG · TABLET · TEVA CANADA LIMITED
DIN 00869023 · ended Jul 11, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-PINDOLOL
15MG · TABLET · TEVA CANADA LIMITED
DIN 00869023 · ended Jul 4, 2023 · Disruption of the manufacture of the drug.
Discontinued
APO-PINDOL TAB 15MG
15MG · TABLET · APOTEX INC
DIN 00755893
Resolved
APO-PINDOL TAB 5MG
5MG · TABLET · APOTEX INC
DIN 00755877 · ended Feb 8, 2022 · Disruption of the manufacture of the drug.
Resolved
APO-PINDOL TAB 10MG
10MG · TABLET · APOTEX INC
DIN 00755885 · ended Feb 8, 2022 · Shortage of an active ingredient.
Discontinued
APO-PINDOL TAB 5MG
5MG · TABLET · APOTEX INC
DIN 00755877
Discontinued
APO-PINDOL TAB 10MG
10MG · TABLET · APOTEX INC
DIN 00755885
Resolved
VISKEN
5MG · TABLET · ARALEZ PHARMACEUTICALS CANADA INC
DIN 00417270 · ended Dec 1, 2021 · Disruption of the manufacture of the drug.

Showing 12 of 21 reports. All reports are on file with Health Canada.

What's happening

Pindolol is currently affected by 2 active shortage reports filed with Health Canada by XEDITON PHARMACEUTICALS INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Pindolol is classified under “BETA BLOCKING AGENTS” (ATC C07AA).

Recent changes

Common questions

What is Pindolol used for?

A beta blocker used to treat high blood pressure.

When will Pindolol be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Pindolol in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (beta blocking agents)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.